An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso
NCT04445441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153
Last updated 2021-01-22
Summary
This is an observational study to evaluate the effectiveness of the combinations Hydroxychloroquine + Azithromycin (HCQ-AZ) and Chloroquine + Azithromycin (CQ-AZ) in the treatment of Coronavirus (Covid-19) infection in Burkina Faso.
Conditions
- Coronavirus Infection
Sponsors & Collaborators
-
Centre Muraz
lead OTHER
Principal Investigators
-
Halidou Tinto, PhD · IRSS - URCN
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-24
- Primary Completion
- 2020-09-03
- Completion
- 2020-11-30
Countries
- Burkina Faso
Study Locations
More Related Trials
-
A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
NCT04434144 ·Status: COMPLETED
-
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
NCT04322123 ·Status: COMPLETED ·Phase: PHASE3
-
Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients
NCT04443270 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of Hydroxychloroquine in Covid-19 Patients
NCT04328272 ·Status: UNKNOWN ·Phase: PHASE3
-
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa
NCT00082576 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
NCT00084227 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa
NCT01103713 ·Status: TERMINATED ·Phase: PHASE3
-
Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
NCT04341727 ·Status: TERMINATED ·Phase: PHASE3
-
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
NCT04342650 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537 ·Status: UNKNOWN ·Phase: PHASE2
-
Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
NCT04322396 ·Status: TERMINATED ·Phase: PHASE2
-
Chloroquine as Antiviral Treatment in Coronavirus Infection 2020
NCT04331600 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19
NCT04452617 ·Status: COMPLETED
-
Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients
NCT04371406 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
NCT04481633 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
NCT04847661 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19
NCT04329572 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa
NCT01103063 ·Status: TERMINATED ·Phase: PHASE3
-
Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients
NCT04501965 ·Status: UNKNOWN ·Phase: PHASE2
-
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.
NCT00367653 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
NCT04353245 ·Status: UNKNOWN
-
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
NCT04627467 ·Status: COMPLETED ·Phase: PHASE2
-
HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
NCT04575558 ·Status: WITHDRAWN ·Phase: PHASE2
-
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa
NCT00677833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
NCT04344951 ·Status: TERMINATED ·Phase: PHASE2